ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry
Study ADH.E.R.E.: "Therapeutic ADHerence and Treatment Strategies: Mental Health Registry"
1 other identifier
observational
2,622
0 countries
N/A
Brief Summary
The purpose of this study is to find out how well new treatment plans are followed by outpatients with major mental illnesses (schizophrenia, bipolar disorder, depression, personality disorder) and to determine the relationship between a diagnosis of schizophrenia and compliance with a treatment plan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2005
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 9, 2005
CompletedFirst Posted
Study publicly available on registry
December 12, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2006
CompletedMay 19, 2011
April 1, 2010
December 9, 2005
May 18, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of compliance with different classes of drugs (such as antidepressants and antipsychotics), to determine whether a particular group of drugs is associated with improved compliance.
3 months
Secondary Outcomes (1)
Comparison of compliance with different classes of drugs (such as antidepressants and antipsychotics), to determine whether a particular group of drugs is associated with improved compliance
3 months
Study Arms (2)
001
002
Interventions
Eligibility Criteria
Outpatients diagnosed with schizophrenia, bipolar disorder or depression according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) classification characteristics who have been given a new therapy plan (that may include drug treatment for mental illness, visits to a mental health care worker, or other treatments such as non-medication type of treatments); patients either scheduled for treatment in the next 3 months or already treated for the past 3 months.
You may qualify if:
- Outpatients diagnosed with schizophrenia, bipolar disorder or depression according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) classification characteristics who have been given a new therapy plan (that may include drug treatment for mental illness, visits to a mental health care worker, or other treatments such as non-medication type of treatments)
- Patients either scheduled for treatment in the next 3 months or already treated for the past 3 months
You may not qualify if:
- Patients with psychiatry pathology other than Schizophrenia or schizoaffective disorder/ bipolar disease/major depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Janssen-Cilag S.A. (formerly Janssen Sp) Clinical Trial
Janssen-Cilag, S.A.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 9, 2005
First Posted
December 12, 2005
Study Start
June 1, 2005
Study Completion
June 1, 2006
Last Updated
May 19, 2011
Record last verified: 2010-04